Eve Burstein
Stock Analyst at Bernstein
(2.34)
# 2,658
Out of 4,987 analysts
24
Total ratings
38.46%
Success rate
5.77%
Average return
Main Sectors:
Stocks Rated by Eve Burstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Market Perform | $145 → $125 | $127.62 | -2.05% | 5 | Apr 16, 2025 | |
| NTRA Natera | Maintains: Outperform | $160 → $200 | $179.86 | +11.20% | 4 | Jan 10, 2025 | |
| RVTY Revvity | Maintains: Outperform | $150 → $145 | $87.76 | +65.22% | 2 | Nov 5, 2024 | |
| WAT Waters | Maintains: Market Perform | $345 → $360 | $306.38 | +17.50% | 2 | Nov 4, 2024 | |
| EXAS Exact Sciences | Maintains: Outperform | $75 → $90 | $53.59 | +67.94% | 2 | Oct 30, 2024 | |
| GH Guardant Health | Maintains: Outperform | $40 → $35 | $58.80 | -40.48% | 2 | Oct 30, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Market Perform | $625 → $620 | $481.10 | +28.87% | 3 | Oct 24, 2024 | |
| PACB Pacific Biosciences of California | Maintains: Outperform | $9 → $2.5 | $1.28 | +95.31% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Initiates: Market Perform | $22 | $12.86 | +71.07% | 1 | Sep 28, 2023 | |
| ILMN Illumina | Initiates: Underperform | $111 | $103.03 | +7.74% | 1 | Sep 28, 2023 |
Agilent Technologies
Apr 16, 2025
Maintains: Market Perform
Price Target: $145 → $125
Current: $127.62
Upside: -2.05%
Natera
Jan 10, 2025
Maintains: Outperform
Price Target: $160 → $200
Current: $179.86
Upside: +11.20%
Revvity
Nov 5, 2024
Maintains: Outperform
Price Target: $150 → $145
Current: $87.76
Upside: +65.22%
Waters
Nov 4, 2024
Maintains: Market Perform
Price Target: $345 → $360
Current: $306.38
Upside: +17.50%
Exact Sciences
Oct 30, 2024
Maintains: Outperform
Price Target: $75 → $90
Current: $53.59
Upside: +67.94%
Guardant Health
Oct 30, 2024
Maintains: Outperform
Price Target: $40 → $35
Current: $58.80
Upside: -40.48%
Thermo Fisher Scientific
Oct 24, 2024
Maintains: Market Perform
Price Target: $625 → $620
Current: $481.10
Upside: +28.87%
Pacific Biosciences of California
Apr 18, 2024
Maintains: Outperform
Price Target: $9 → $2.5
Current: $1.28
Upside: +95.31%
Avantor
Sep 28, 2023
Initiates: Market Perform
Price Target: $22
Current: $12.86
Upside: +71.07%
Illumina
Sep 28, 2023
Initiates: Underperform
Price Target: $111
Current: $103.03
Upside: +7.74%